
Opinion|Videos|November 25, 2025
The Burden and Unmet Needs Associated with Desmoid Tumors
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.
Advertisement
Episodes in this series

Panelists discuss the questions below in this video.
- There any molecular biomarkers that are commonly associated with desmoid tumor?
- What is the role of biomarker testing in patients with suspected diagnosis? What makes the definitive diagnosis?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
2
Communication of Launch Prices by Drug Companies, 2022-2024
3
Top 5 Most-Read News Stories of 2025
4
Team-Based Strategies Advance Cardio-Renal-Metabolic Health
5










































